Sofia Vasilakaki

446 total citations
16 papers, 326 citations indexed

About

Sofia Vasilakaki is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Sofia Vasilakaki has authored 16 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Sofia Vasilakaki's work include Protein Kinase Regulation and GTPase Signaling (4 papers), Endometriosis Research and Treatment (3 papers) and Protein Structure and Dynamics (2 papers). Sofia Vasilakaki is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (4 papers), Endometriosis Research and Treatment (3 papers) and Protein Structure and Dynamics (2 papers). Sofia Vasilakaki collaborates with scholars based in Greece, Switzerland and United Kingdom. Sofia Vasilakaki's co-authors include Nikolaos Machairiotis, Nikolaos Thomakos, George Kokotos, Aikaterini Nikolaou, Maroula G. Kokotou, Christiana Mantzourani, Efrosini Barbayianni, Thomas Mavromoustakos, Zoe Cournia and Dimitris Dellis and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Sofia Vasilakaki

16 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia Vasilakaki Greece 10 117 109 81 70 33 16 326
Michael C. Doody United States 10 132 1.1× 219 2.0× 88 1.1× 59 0.8× 38 1.2× 15 429
Sarah Ciccone Italy 10 43 0.4× 291 2.7× 5 0.1× 81 1.2× 28 0.8× 10 501
Jean-Claude Philippe France 9 38 0.3× 152 1.4× 14 0.2× 12 0.2× 7 0.2× 12 412
T Tanaka Japan 8 26 0.2× 275 2.5× 11 0.1× 22 0.3× 18 0.5× 9 485
Setsuko Yamamoto Japan 14 11 0.1× 215 2.0× 11 0.1× 67 1.0× 14 0.4× 40 430
N. Devleeschouwer Belgium 13 33 0.3× 154 1.4× 6 0.1× 35 0.5× 4 0.1× 30 453
B. Valcaccia United Kingdom 8 68 0.6× 109 1.0× 12 0.1× 12 0.2× 5 0.2× 8 364
Ella Twaddle Australia 12 76 0.6× 117 1.1× 44 0.5× 46 0.7× 1 0.0× 16 455
J. Bruynseels Belgium 9 20 0.2× 137 1.3× 4 0.0× 22 0.3× 6 0.2× 18 405
Christian Derappe France 10 29 0.2× 293 2.7× 9 0.1× 90 1.3× 10 0.3× 35 425

Countries citing papers authored by Sofia Vasilakaki

Since Specialization
Citations

This map shows the geographic impact of Sofia Vasilakaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Vasilakaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Vasilakaki more than expected).

Fields of papers citing papers by Sofia Vasilakaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Vasilakaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Vasilakaki. The network helps show where Sofia Vasilakaki may publish in the future.

Co-authorship network of co-authors of Sofia Vasilakaki

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Vasilakaki. A scholar is included among the top collaborators of Sofia Vasilakaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Vasilakaki. Sofia Vasilakaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vasilakaki, Sofia, et al.. (2023). Molecular Interactions of Antibodies with PD-1/PD-L1 Proteins. Immunotherapy. 16(1). 21–28. 1 indexed citations
2.
Mantzourani, Christiana, et al.. (2022). The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19. Expert Opinion on Drug Discovery. 17(3). 231–246. 21 indexed citations
3.
Mantzourani, Christiana, et al.. (2021). The design and discovery of phospholipase A2 inhibitors for the treatment of inflammatory diseases. Expert Opinion on Drug Discovery. 16(11). 1287–1305. 24 indexed citations
4.
Augsburger, Fiona, Sofia Vasilakaki, Vassilios Myrianthopoulos, et al.. (2021). Novel Aryl-Substituted Pyrimidones as Inhibitors of 3-Mercaptopyruvate Sulfurtransferase with Antiproliferative Efficacy in Colon Cancer. Journal of Medicinal Chemistry. 64(9). 6221–6240. 19 indexed citations
5.
Machairiotis, Nikolaos, Sofia Vasilakaki, & Nikolaos Thomakos. (2021). Inflammatory Mediators and Pain in Endometriosis: A Systematic Review. Biomedicines. 9(1). 54–54. 103 indexed citations
6.
Machairiotis, Nikolaos, et al.. (2021). Nutrients that modulate gestational diabetes mellitus: A systematic review of cohort studies Jan 2019‐Jan 2020. International Journal of Clinical Practice. 75(8). e14033–e14033. 4 indexed citations
7.
Θεοδωροπούλου, Μαρία, Christiana Mantzourani, Sofia Vasilakaki, et al.. (2021). α-Ketoheterocycles Able to Inhibit the Generation of Prostaglandin E2 (PGE2) in Rat Mesangial Cells. Biomolecules. 11(2). 275–275. 1 indexed citations
8.
Vasilakaki, Sofia, Johannes Kraml, Michael Schauperl, Klaus R. Liedl, & George Kokotos. (2020). Hydration thermodynamics of cytosolic phospholipase A2 GIVA predict its membrane-associated parts and its highly hydrated binding site. Journal of Biomolecular Structure and Dynamics. 39(3). 953–959. 1 indexed citations
9.
Machairiotis, Nikolaos, et al.. (2019). Natural products: Potential lead compounds for the treatment of endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 245. 7–12. 12 indexed citations
10.
Sapalidis, Konstantinos, Nikolaos Machairiotis, Paul Zarogoulidis, et al.. (2019). Genes’ Interactions: A Major Contributor to the Malignant Transformation of Endometriosis. International Journal of Molecular Sciences. 20(8). 1842–1842. 13 indexed citations
11.
Nikolaou, Aikaterini, Maroula G. Kokotou, Sofia Vasilakaki, & George Kokotos. (2018). Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1864(6). 941–956. 65 indexed citations
12.
Vasilakaki, Sofia, Olivier Lozach, Leonidas G. Alexopoulos, et al.. (2018). A Facile Consensus Ranking Approach Enhances Virtual Screening Robustness and Identifies a Cell-Active DYRK1α Inhibitor. Future Medicinal Chemistry. 10(20). 2411–2430. 5 indexed citations
13.
Vasilakaki, Sofia, et al.. (2018). Small Peptides Able to Suppress Prostaglandin E2 Generation in Renal Mesangial Cells. Molecules. 23(1). 158–158. 7 indexed citations
14.
15.
Vasilakaki, Sofia, Efrosini Barbayianni, Georgios Leonis, et al.. (2016). Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations. Bioorganic & Medicinal Chemistry. 24(8). 1683–1695. 22 indexed citations
16.
Vasilakaki, Sofia, Efrosini Barbayianni, Victoria Magrioti, et al.. (2016). Inhibitors of secreted phospholipase A2 suppress the release of PGE2 in renal mesangial cells. Bioorganic & Medicinal Chemistry. 24(13). 3029–3034. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026